Related references
Note: Only part of the references are listed.Ras-association domain family 1C protein promotes breast cancer cell migration and attenuates apoptosis
Mark E. Reeves et al.
BMC CANCER (2010)
RASSF1A interacts with and activates the mitotic kinase Aurora-A
L. Liu et al.
ONCOGENE (2008)
Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro-entero-pancreatic system
Christian N. Arnold et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Wnt signaling regulates pancreatic β cell proliferation
Ingrid C. Rulifson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma
Janos Geli et al.
ENDOCRINE-RELATED CANCER (2007)
RASSF1C, an isoform of the tumor suppressor RASSF1A, promotes the accumulation of β-catenin by interacting with βTrCP
Emilie Estrabaud et al.
CANCER RESEARCH (2007)
Epigenetic alterations in RASSF1A in human aberrant crypt foci
Emily J. Greenspan et al.
CARCINOGENESIS (2006)
Quantitative evaluation of RASSFIA methylation in the non-lesional, regenerative and neoplastic liver
Sonia Di Gioia et al.
BMC CANCER (2006)
RASSFIA promoter methylation and 3p21.3 loss of heterozygosity are features of foregut, but not midgut and hindgut, malignant endocrine tumours
S Pizzi et al.
JOURNAL OF PATHOLOGY (2005)
Distinct methylation patterns of benign and malignant liver tumors revealed by quantitative methylation profiling
U Lehmann et al.
CLINICAL CANCER RESEARCH (2005)
Role of the ras-association domain family 1 tumor suppressor gene in human cancers
A Agathanggelou et al.
CANCER RESEARCH (2005)
Inactivation of RASSF1A tumor suppressor gene by aberrant promoter hypermethylation in human pituitary adenomas
ZR Qian et al.
LABORATORY INVESTIGATION (2005)
Early occurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesis
MZ Xing et al.
CANCER RESEARCH (2004)
Promoter hypermethylation of resected bronchial margins: A field defect of changes?
MZ Guo et al.
CLINICAL CANCER RESEARCH (2004)
A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stability
MD Vos et al.
CANCER RESEARCH (2004)
Molecular profiling and classification of sporadic renal cell carcinoma by quantitative methylation analysis
ML Gonzalgo et al.
CLINICAL CANCER RESEARCH (2004)
Tumor suppressor RASSF1A is a microtubule-binding protein that stabilizes microtubules and induces G2/M arrest
R Rong et al.
ONCOGENE (2004)
Control of microtubule stability by the RASSF1A tumor suppressor
LM Liu et al.
ONCOGENE (2003)
Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples
T Waki et al.
ONCOGENE (2003)
Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma
R Dammann et al.
ONCOGENE (2003)
Frequent hypermethylation of the RASSF1A gene in prostate cancer
LM Liu et al.
ONCOGENE (2002)
The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation
L Shivakumar et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Quantitative assessment of promoter hypermethylation during breast cancer development
U Lehmann et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours
A Agathanggelou et al.
ONCOGENE (2001)
Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3
R Dammann et al.
NATURE GENETICS (2000)
Share Paper
